|
Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss Clinical research trials and Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss. Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss clinical trial. Human subjects often get the best healthcare possible for their Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss  Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss
Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss
For Condition: Hearing Loss
Status: Recruiting
Sponsor(s): Department of Veterans Affairs ,
Synopsis: Tinnitus is a prevalent issue for veterans who are proportionally more hearing-impaired than the civilian population. This study will be conducted as three concurrent projects designed to develop an efficient clinical technique to quantify tinnitus perception: (1)Laboratory development of the automated technique for comprehensive tinnitus quantification;(2)Development of a technique to test for tinnitus "malingering"; and (3)Evaluation of the automated technique in the clinical environment.
Details: Because of its close association with sensorineural hearing loss, tinnitus is a prevalent issue for veterans who are proportionally more hearing-impaired than the civilian population. The VA system disburses $110 million per year to over 115,000 veterans for their service-connected tinnitus disability, thus it is clearly a problem for veterans and for the VA. Unfortunately, most VAMCs do not have systematic clinical care available for their veterans suffering from tinnitus. The most obvious needs are to develop effective treatment methodologies for veterans, and to standardize a procedure for quantifying the disorder. Each of these concerns is a focus of this laboratory, and the present proposal addresses the latter need as a continuation study to develop reliable techniques to measure tinnitus. The goal of this proposed study is a fully functional system, documented for response reliability and ready for clinical implementation at VA audiology clinics outside of Portland. To achieve that end goal, the study will be conducted as three concurrent projects: (1) Further laboratory development of the automated technique for comprehensive tinnitus quantification; (2) Development of a technique to test for tinnitus "malingering"; and (3) Evaluation of the automated technique in the clinical environment. For Project 1, a series of experiments is proposed to reduce the time of testing, and to add new measurement capabilities. Each experiment will involve specification, design, and implementation of program modifications, human subject testing, analysis of results, and further modifications as indicated. Another series of experiments (Project 2) will be conducted to develop a tinnitus malingering exam. With such a test, veterans with true tinnitus would provide reliable responses, while those feigning tinnitus would have difficulty responding reliably. For Project 3, a duplicate measurement system will be installed at the Portland VA Regional Tinnitus Clinic. The automated technique will be used to quantify tinnitus in veteran patients during their tinnitus evaluation. Patients will be invited to return for repeat testing, which will provide reliability data for clinical responses. This project will promote clinical feedback that will be important for final development of the system as a clinical tool. The three projects outlined above are designed to develop an efficient clinical technique to quantify tinnitus perception. Because the technique is computer automated, its implementation at VA clinics will involve a minimum of training and expenditure. The technique is further expected to impact the medical care of non-VA clinics, and could
Eligibility:
Study Type: Observational, Screening, Longitudinal, Defined Population, Prospective Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Hearing impaired
Total Enrollment: 50
Location and Contact Information:
Overall Study Official:
JohnFryer, , Department of Veterans Affairs, Program Analysis and Review Section (PARS), Rehabilitation Research & Development Service
VAMC, Portland *Recruiting*
Portland, Oregon,
United States
Recruiting Steven Hefeneider 503-220-3428
Additional Information:
Study ID Numbers: C2299;
Study Start Date: August 2000
Record last reviewed: January 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00013468
Other Hearing Loss Studies:
1. Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss
2. Epidemiology of Hearing Loss in Diabetic and Non-Diabetic Veterans
3. Quantifying Auditory Perceptual Learning Following Hearing Aid Fitting
Related Studies:
Other Hearing Loss Clinical Trials
Other Oregon Clinical Trials
Other Portland Clinical Trials
Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss
|
|
|
|
|
|
|
|
